Adherence to and persistence with zoledronic acid treatment for osteoporosis—reasons for early discontinuation

SUMMARY: This retrospective study reports 81% long-term (> 3 years) adherence to and 77% persistence with zoledronic acid (ZA) treatment in osteoporosis patients, with ZA being costfree for patients. Eight percent of patients discontinued treatment because of adverse events (AEs), with a tendency...

Descripción completa

Detalles Bibliográficos
Autores principales: Spångeus, Anna, Johansson, Simon, Woisetschläger, Mischa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer London 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7165128/
https://www.ncbi.nlm.nih.gov/pubmed/32303862
http://dx.doi.org/10.1007/s11657-020-00733-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7165128/
https://www.ncbi.nlm.nih.gov/pubmed/32303862
http://dx.doi.org/10.1007/s11657-020-00733-4

Ejemplares similares